Particle.news
Download on the App Store

Apollo Hospitals Q2 Profit Up 26% on Specialty Care as Bed Expansion Gets Underway

Higher-value specialty treatments offset a seasonal drop in medical admissions.

Overview

  • Consolidated revenue rose 13% year-on-year to ₹6,304 crore as net profit increased to ₹477 crore.
  • Hospital division revenue grew 9% to ₹3,169 crore while occupancy eased to 69% from 73% a year earlier.
  • CONGO specialties expanded about 14% and now account for roughly 60% of group revenue.
  • Retail and pharmacy operations strengthened, with AHLL revenue up 17% to ₹474 crore and Apollo HealthCo up 17% to ₹2,661 crore, delivering ₹73 crore in profit and lower online losses.
  • A 1,600-bed expansion over 15–18 months is in progress with ₹2,000 crore of a ₹3,500 crore outlay already spent, and the CCI cleared a restructuring involving Apollo HealthCo, Keimed and Apollo Healthtech.